Colorectal cancer in inflammatory bowel disease

Karen L. Krok, Gary R. Lichtenstein

Research output: Contribution to journalReview articlepeer-review

28 Scopus citations


Purpose of review: Patients with inflammatory bowel disease, either Crohn disease or ulcerative colitis, are at an increased risk for developing colorectal carcinoma. Recent findings: Surveillance colonoscopy, although never formally evaluated in a prospective controlled trial, is performed in an effort to reduce this risk. Novel methods of detecting dysplasia are constantly being evaluated, including chromoendoscopy and biomarkers of carcinoma, in an attempt to stratify patients who are at a higher risk of developing high-grade dysplasia or carcinoma. Summary: Because of the potential impact on quality of life and life expectancy, an optimal strategy for reducing the risk of developing colorectal cancer in patients with inflammatory bowel disease needs to be defined.

Original languageEnglish (US)
Pages (from-to)43-48
Number of pages6
JournalCurrent Opinion in Gastroenterology
Issue number1
StatePublished - Jan 2004

All Science Journal Classification (ASJC) codes

  • Gastroenterology


Dive into the research topics of 'Colorectal cancer in inflammatory bowel disease'. Together they form a unique fingerprint.

Cite this